NOVOCURE TTF UPDATE:

The NovoTTF-100A system is a portable, non-invasive medical device that slows and reverses tumor growth by creating low intensity, alternating electric fields within the tumor.

A recent update on the GBM patients from the original pilot study of 20 individuals in 2004 and 2005, shows that 4 out of 20 patients (20%) are alive in good health with no signs of recurrence and no longer receiving any treatment more than 7 yrs after starting the trial.

The predicted 5-year survival rate for these patients with standard treatment (surgery and TMZ) is about 4%.

Long-term survival of patients suffering from glioblastoma multiforme treated with tumor treating fields.

CLICK HERE TO VIEW A LIST OF NOVO CURE TTF TREATMENT CENTRES


Speak Your Mind

*